The studies reviewed were small and heterogeneous and it is unclear which interventions were the most successful.

Early device failures, prior authorizations, and not receiving 90-days’ worth of supplies contribute to the problem.

Patients with diabetes who use metformin for at least 5 consecutive years are less likely to develop AMD, particularly the ...

The experimental cholesterol drug obicetrapib slowed Alzheimer’s biomarkers, over 12 months in patients with cardiovascular ...